These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 16504177
1. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Ling Z, Zhu Y, Tong Cw, Snyder JA, Lipton JW, Carvey PM. Exp Neurol; 2006 Jun; 199(2):499-512. PubMed ID: 16504177 [Abstract] [Full Text] [Related]
2. Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. Ling Z, Zhu Y, Tong CW, Snyder JA, Lipton JW, Carvey PM. Exp Neurol; 2009 Apr; 216(2):312-20. PubMed ID: 19133261 [Abstract] [Full Text] [Related]
3. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Ling Z, Chang QA, Tong CW, Leurgans SE, Lipton JW, Carvey PM. Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876 [Abstract] [Full Text] [Related]
4. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Ling ZD, Chang Q, Lipton JW, Tong CW, Landers TM, Carvey PM. Neuroscience; 2004 Dec; 124(3):619-28. PubMed ID: 14980732 [Abstract] [Full Text] [Related]
5. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Wang S, Yan JY, Lo YK, Carvey PM, Ling Z. Brain Res; 2009 Apr 10; 1265():196-204. PubMed ID: 19236855 [Abstract] [Full Text] [Related]
6. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Schapira AH, Jenner P. Exp Neurol; 2008 Aug 10; 212(2):522-31. PubMed ID: 18571649 [Abstract] [Full Text] [Related]
7. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. Peng GS, Li G, Tzeng NS, Chen PS, Chuang DM, Hsu YD, Yang S, Hong JS. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):162-9. PubMed ID: 15790540 [Abstract] [Full Text] [Related]
8. Prenatal inflammatory effects on nigrostriatal development in organotypic cultures. Snyder-Keller A, Stark PF. Brain Res; 2008 Oct 03; 1233():160-7. PubMed ID: 18710655 [Abstract] [Full Text] [Related]
9. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Iravani MM, Leung CC, Sadeghian M, Haddon CO, Rose S, Jenner P. Eur J Neurosci; 2005 Jul 03; 22(2):317-30. PubMed ID: 16045485 [Abstract] [Full Text] [Related]
10. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Zhu Y, Carvey PM, Ling Z. Neurochem Int; 2007 Mar 03; 50(4):671-80. PubMed ID: 17291629 [Abstract] [Full Text] [Related]
11. Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration. Mangano EN, Hayley S. Neurobiol Aging; 2009 Sep 03; 30(9):1361-78. PubMed ID: 18187236 [Abstract] [Full Text] [Related]
12. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. Liu B, Jiang JW, Wilson BC, Du L, Yang SN, Wang JY, Wu GC, Cao XD, Hong JS. J Pharmacol Exp Ther; 2000 Oct 03; 295(1):125-32. PubMed ID: 10991969 [Abstract] [Full Text] [Related]
13. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Wu SY, Wang TF, Yu L, Jen CJ, Chuang JI, Wu FS, Wu CW, Kuo YM. Brain Behav Immun; 2011 Jan 03; 25(1):135-46. PubMed ID: 20851176 [Abstract] [Full Text] [Related]
14. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M. J Neurosci Res; 2007 Jun 03; 85(8):1752-61. PubMed ID: 17469135 [Abstract] [Full Text] [Related]
15. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R. Acta Neuropathol; 2008 Jul 03; 116(1):47-55. PubMed ID: 18343932 [Abstract] [Full Text] [Related]
16. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G. J Neurochem; 2007 Mar 03; 100(5):1375-86. PubMed ID: 17254027 [Abstract] [Full Text] [Related]
17. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Chen HQ, Jin ZY, Wang XJ, Xu XM, Deng L, Zhao JW. Neurosci Lett; 2008 Dec 26; 448(2):175-9. PubMed ID: 18952146 [Abstract] [Full Text] [Related]
18. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Tomás-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, Machado A, Venero JL. Neurobiol Dis; 2004 Jun 26; 16(1):190-201. PubMed ID: 15207276 [Abstract] [Full Text] [Related]
19. [Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease]. Wang PQ, Sun SG, Qiao X. Zhonghua Yi Xue Za Zhi; 2009 May 19; 89(19):1346-50. PubMed ID: 19615192 [Abstract] [Full Text] [Related]